Collombat_P's profile picture. INSERM: Director of Research - Directeur de Recherche (DR1)
DiogenX: Co-founder and Scientific Advisor - Co-fondateur et Conseiller Scientifique

Collombat Patrick

@Collombat_P

INSERM: Director of Research - Directeur de Recherche (DR1) DiogenX: Co-founder and Scientific Advisor - Co-fondateur et Conseiller Scientifique

DiogenX, la startup issue de nos travaux au laboratoire, a levé 30 millions de dollars pour sa Série A. Très heureux/honoré d'avoir clôturé ce tour de financement avec un tel syndicat d'acteurs majeurshttps://diogenx.com/PR_FR.pdf

Collombat_P's tweet image. DiogenX, la startup issue de nos travaux au laboratoire, a levé 30 millions de dollars pour sa Série A. Très heureux/honoré d'avoir clôturé ce tour de financement avec un tel syndicat d'acteurs majeurshttps://diogenx.com/PR_FR.pdf

DiogenX, the startup stemming for our laboratory, raised 30 million USD for its Series A! Truly happy/honoured to have successfully completed this round of financing with such a syndicate of major players! Press release link: diogenx.com/PR_EN.pdf

Collombat_P's tweet image. DiogenX, the startup stemming for our laboratory, raised 30 million USD for its Series A! Truly happy/honoured to have successfully completed this round of financing with such a syndicate of major players! 
Press release link: diogenx.com/PR_EN.pdf

Delighted to launch our own company, DiogenX, with the support of Advent France Biotechnology, Boehringer Ingelheim Venture Fund (DE) and JDRF T1D Fund (US).

Collombat_P's tweet image. Delighted to launch our own company, DiogenX, with the support of Advent France Biotechnology, Boehringer Ingelheim Venture Fund (DE) and JDRF T1D Fund (US).
Collombat_P's tweet image. Delighted to launch our own company, DiogenX, with the support of Advent France Biotechnology, Boehringer Ingelheim Venture Fund (DE) and JDRF T1D Fund (US).

Très heureux de lancer notre propre compagnie, DiogenX, avec le support de Advent France Biotechnology, Boehringer Ingelheim Venture Fund (Allemagne) et JDRF T1D Fund (Etats-unis).

Collombat_P's tweet image. Très heureux de lancer notre propre compagnie, DiogenX, avec le support de  Advent France Biotechnology, Boehringer Ingelheim Venture Fund (Allemagne) et JDRF T1D Fund (Etats-unis).
Collombat_P's tweet image. Très heureux de lancer notre propre compagnie, DiogenX, avec le support de  Advent France Biotechnology, Boehringer Ingelheim Venture Fund (Allemagne) et JDRF T1D Fund (Etats-unis).

Type 1 diabetes: Can insulin-producing cells be regenerated?: sciencedaily.com/releases/2013/…


Loading...

Something went wrong.


Something went wrong.